Janus Henderson Group Plc - Sep 30, 2025 SCHEDULE 13G Report for INOVIO PHARAMACEUITICALS, INC. Common Stock (INO)

Filing Manager
JANUS HENDERSON GROUP PLC
Reporting Manager
JANUS HENDERSON GROUP PLC
Security
INOVIO PHARAMACEUITICALS, INC. Common Stock
Symbol
INO
Shares outstanding
52.7M shares
Disclosed Ownership
3.27M shares
Ownership
6.2%
Form type
SCHEDULE 13G
Date filed
11/14/2025, 10:34 AM
Date of event
Sep 30, 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
JANUS HENDERSON GROUP PLC 6.2% 3.27M 0 3.27M Kristin Mariani Head of North America Compliance, CCO
Janus Henderson Biotech Innovation Master Fund Ltd 5.3% 2.8M 0 2.8M Kristin Mariani Head of North America Compliance, CCO